LSU Health Shreveport has established the Emerging Viral Threat (EVT) Laboratory to address the need for faster detection and processing of COVID-19 tests.
The requirements for admission to the School of Graduate Studies are:
- A baccalaureate degree from a college or university approved by a regional accrediting agency.
- A grade point average of at least 2.5 for under graduate work, and 3.0 for graduate work, on a 4 point scale and based upon all work for which a grade is given.
- Recent Graduate Record Examination (GRE) scores. Minimum score requirements vary with the degree program.
- Good standing at the most recent educational institution attended.
- International students must present acceptable scores (80 or better) on the Test of English as a Foreign Language (TOEFL) examination before they will be accepted as graduate students or at least a 6.5 overall band score on the IELTS. These examinations are offered several times a year throughout the world.
- Final acceptance is contingent upon acceptance by one of the Departments offering graduate instruction leading to advanced degrees.
- Note: Individual Departments may establish more stringent requirements than the minimal standards of the School of the Graduate Studies.
Types of Admissions
Domestic students meeting all requirements are granted unconditional admission. Applicants who fail to meet all qualifications but who are nevertheless judged by the Department concerned and by the Dean to show promise for successful graduate work may be considered for probationary admission on the merits of their individual cases. Applicants who appear to be admissible but who are unable, for good reason, to supply the required credentials prior to the stated deadline may request provisional admission. In such cases, complete credentials must be received not later than sixty days after the first day of classes (forty-five days in the Summer term).
Apply to our programs at https://gradcas2020.liaisoncas.com/applicant-ux/#/login
LSU Health Shreveport is participating in the GradCAS Centralized Application Service (GradCAS) in the 2020 application cycle. The application cycle will open on September 5, 2019. The application deadline is January 31, 2020. The application process is outlined below:
- Create a GradCAS application. Search for our programs at Louisiana State University Health Sciences Center Shreveport.
- Send all information, including GRE and TOEFL scores, directly to GradCAS.
- Send all official transcripts to the GradCAS Transcript processing center. Transcripts which show transfer credit from other colleges you have attended are not acceptable. Transcripts from institutions outside the United States must be evaluated by a global credential service (recommended companies are ECE, WES, and GCE).
GradCAS Transcript Processing Center
P.O. Box 9217
Watertown, MA 02471
- International students must submit scores for both the GRE and TOEFL. The TOEFL must be taken unless the applicant has received at least a Bachelor’s degree from an American University. International students should have their IELTS scores mailed directly to LSU Health Shreveport at the following address:
School of Graduate Studies
LSU Health Shreveport
P.O. Box 33932
Shreveport, LA 71130
Having trouble accessing the application? The preferred browsers are Google Chrome or Firefox.
More information is available at the GradCAS help center. If you have questions about your application status, please contact your GradCAS Customer Service Representative at (857) 304-2086 or GradCASinfo@liaisonedu.com
Why Train in Shreveport-Bossier?
"North Louisiana’s cost of living remains the lowest in the state" - Biz Magazine, Nov. 2019
LSUHS leadership, faculty, staff, students and community supporters recently honored the continued growth of research initiatives and funding at the second annual Research Celebration event held on February 25, 2020.
Internationally recognized for his research on inflammatory vascular pathology, specifically on and the relationship between inflammation and vascular growth and function, Dr. Kevil discovered detailed mechanistic relationships between angiogenesis and inflammation.
Aphios Granted U.S. Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases, which was co-invented by LSU Health Shreveport professor, Dr. J. Steven Alexander.
JanOne Acquires Worldwide, Exclusive License for Promising Treatment of Peripheral Arterial Disease (PAD), TV1001SR, which was invented by LSU Health Shreveport professor and vice chancellor for research, Dr. Chris Kevil.